(Q24240969)

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Etoricoxib in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

A randomized, double-blind, parallel-group study comparing the analgesic effect of etoricoxib to placebo, naproxen sodium, and acetaminophen with codeine using the dental impaction pain model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

The analgesic effect of etoricoxib relative to that of cetaminophen analgesics: a randomized, controlled single-dose study in acute dental impaction pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Etoricoxib provides analgesic efficacy to patients after knee or hip replacement surgery: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Single dose oral rofecoxib for postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

The visual analogue pain intensity scale: what is moderate pain in millimetres?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Single dose oral ibuprofen and diclofenac for postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

The number needed to treat: a clinically useful measure of treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Single dose oral celecoxib for acute postoperative pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Gastrointestinal safety of COX-2 specific inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

NSAIDs, coxibs, and the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Meta-analysis in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: verification from independent data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Single dose oral lumiracoxib for postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Effect of preoperative Cox-II-selective NSAIDs (coxibs) on postoperative outcomes: a systematic review of randomized studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Impact of covert duplicate publication on meta-analysis: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

Developing a database of published reports of randomised clinical trials in pain research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

1 reference

7 January 2021

Seeking a simple measure of analgesia for mega-trials: is a single global assessment good enough?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

7 January 2021

Reporting of Adverse Effects in Clinical Trials Should Be Improved

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004309.PUB2

7 January 2021